Federated Hermes’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306M Sell
1,385,450
-174,848
-11% -$48.4M 0.44% 56
2026
Q1
$461M Buy
1,560,298
+996,222
+177% +$296M 0.75% 26
2025
Q4
$154M Buy
564,076
+551,178
+4,273% +$150M 0.26% 102
2025
Q3
$3.48M Sell
12,898
-10,674
-45% -$2.9M 0.01% 811
2025
Q2
$6.5M Buy
23,572
+21,918
+1,325% +$5.96M 0.01% 661
2025
Q1
$439K Sell
1,654
-23,725
-93% -$5.85M ﹤0.01% 1339
2024
Q4
$5.89M Sell
25,379
-1,287
-5% -$296K 0.01% 666
2024
Q3
$5.88M Buy
26,666
+380
+1% +$78.6K 0.01% 688
2024
Q2
$5.17M Buy
26,286
+532
+2% +$110K 0.01% 708
2024
Q1
$5.54M Sell
25,754
-976
-4% -$205K 0.01% 705
2023
Q4
$5.63M Sell
26,730
-16,702
-38% -$3.56M 0.01% 687
2023
Q3
$8.7M Buy
43,432
+3,302
+8% +$656K 0.02% 569
2023
Q2
$7.44M Sell
40,130
-1,369
-3% -$253K 0.02% 609
2023
Q1
$7.95M Sell
41,499
-20,015
-33% -$3.62M 0.02% 601
2022
Q4
$10.3M Buy
61,514
+14,180
+30% +$2.46M 0.03% 531
2022
Q3
$8.38M Sell
47,334
-15,819
-25% -$3.13M 0.02% 568
2022
Q2
$12.9M Buy
63,153
+18,583
+42% +$3.94M 0.04% 490
2022
Q1
$10.6M Buy
44,570
+40,153
+909% +$9.43M 0.02% 587
2021
Q4
$1.01M Sell
4,417
-95
-2% -$20.9K ﹤0.01% 1272
2021
Q3
$873K Buy
4,512
+18
+0.4% +$3.65K ﹤0.01% 1333
2021
Q2
$956K Buy
4,494
+171
+4% +$36.1K ﹤0.01% 1335
2021
Q1
$883K Buy
4,323
+554
+15% +$109K ﹤0.01% 1422
2020
Q4
$686K Sell
3,769
-215
-5% -$36.6K ﹤0.01% 1448
2020
Q3
$667K Sell
3,984
-1,177
-23% -$198K ﹤0.01% 1396
2020
Q2
$839K Sell
5,161
-47
-0.9% -$8.43K ﹤0.01% 1313
2020
Q1
$901K Sell
5,208
-95,206
-95% -$18.9M ﹤0.01% 1178
2019
Q4
$20.2M Buy
100,414
+95,492
+1,940% +$19.6M 0.04% 411
2019
Q3
$1.04M Buy
4,922
+1,172
+31% +$245K ﹤0.01% 1258
2019
Q2
$728K Sell
3,750
-1,138
-23% -$210K ﹤0.01% 1365
2019
Q1
$804K Sell
4,888
-38,443
-89% -$6.8M ﹤0.01% 1364
2018
Q4
$8.15M Buy
43,331
+38,742
+844% +$7.15M 0.02% 566
2018
Q3
$781K Sell
4,589
-8,317
-64% -$1.4M ﹤0.01% 1404
2018
Q2
$2.12M Sell
12,906
-1,318
-9% -$215K 0.01% 995
2018
Q1
$2.3M Sell
14,224
-101,461
-88% -$16.2M 0.01% 905
2017
Q4
$16.9M Buy
115,685
+108,519
+1,514% +$15.5M 0.05% 299
2017
Q3
$972K Sell
7,166
-290
-4% -$36.6K ﹤0.01% 1210
2017
Q2
$934K Buy
7,456
+1,636
+28% +$196K ﹤0.01% 1228
2017
Q1
$691K Sell
5,820
-58,571
-91% -$7.04M ﹤0.01% 1265
2016
Q4
$7.43M Buy
64,391
+40,594
+171% +$4.52M 0.02% 464
2016
Q3
$2.49M Buy
23,797
+9,863
+71% +$1.03M 0.01% 773
2016
Q2
$1.36M Buy
13,934
+4,754
+52% +$449K ﹤0.01% 998
2016
Q1
$882K Sell
9,180
-78,252
-90% -$7.12M ﹤0.01% 1115
2015
Q4
$7.92M Buy
87,432
+77,962
+823% +$7.34M 0.03% 480
2015
Q3
$878K Buy
9,470
+266
+3% +$25.3K ﹤0.01% 1128
2015
Q2
$857K Sell
9,204
-4,917
-35% -$459K ﹤0.01% 1202
2015
Q1
$1.34M Buy
14,121
+3,654
+35% +$339K ﹤0.01% 1089
2014
Q4
$928K Sell
10,467
-725
-6% -$61.4K ﹤0.01% 1211
2014
Q3
$895K Sell
11,192
-281
-2% -$21.2K ﹤0.01% 1225
2014
Q2
$814K Buy
11,473
+1,152
+11% +$81.1K ﹤0.01% 1226
2014
Q1
$764K Sell
10,321
-1,179
-10% -$88.9K ﹤0.01% 1236
2013
Q4
$902K Buy
11,500
+188
+2% +$14.7K ﹤0.01% 1188
2013
Q3
$836K Buy
11,312
+976
+9% +$71.9K ﹤0.01% 1185
2013
Q2
$785K Buy
+10,336
New +$678K ﹤0.01% 1165

Other funds holding CME

Federated Hermes's CME Position: Q2 2026 in Review

Federated Hermes reduced its CME Group (CME) stake by 11% in Q2 2026, selling an estimated $48.4M and leaving 1,385,450 shares worth $306M. The position accounts for 0.44% of the portfolio, ranked #56.

Federated Hermes first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $461M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Federated Hermes held 1,385,450 shares of CME Group worth $306M as of Q2 2026.
  • Federated Hermes sold 174,848 CME Group shares in Q2 2026, an estimated $48.4M.
  • CME Group made up 0.44% of Federated Hermes's portfolio in Q2 2026, its #56 holding.
  • Federated Hermes first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Federated Hermes's CME Group position peaked at $461M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.